
Issue 5: 15 March 2025
CD34+ Stem Cell Boost post CAR-T
Cytopenias Secondary to CD19-Targeted CAR-T Cell Therapy
National ICE-T Conference, Orlando; Here we come!!
USMIRC at TCT meeting (Hawaii)
USMIRC social media selected posts.
Modakafusp Alfa for Relapsed/Refractory Multiple Myeloma
USMIRC March Challenge Case!!

USMIRC News 4th issue 9-2-2025
Talquetamab & Dysgeusia!!!
Infections with Bispecific Antibodies in Hematologic Malignancies!
USMIRC: A Catalyst for Equitable
Access and Education
USMIRC International
USMIRC social media selected posts.
RedirecTT-1 Study - Talquetamab plus Teclistamab for Relapsed/Refractory Multiple Myeloma
